PIA
HELP

Powell Investment Advisors’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Powell Investment Advisors’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,579
Closed -$16.3K – 153
2024
Q2 		$16.3K Hold
1,579
– – 0.01% 145
2024
Q1 		$24.8K Hold
1,579
– – 0.01% 141
2023
Q4 		$24.6K Hold
1,579
– – 0.01% 144
2023
Q3 		$31.9K Hold
1,579
– – 0.02% 134
2023
Q2 		$22.7K Hold
1,579
– – 0.01% 127
2023
Q1 		$23.1K Hold
1,579
– – 0.01% 127
2022
Q4 		$17.8K Hold
1,579
– – 0.01% 123
2022
Q3 		$29K Hold
1,579
– – 0.02% 120
2022
Q2 		$34K Buy
1,579
+421
+36% +$10.2K 0.02% 133
2022
Q1 		$36K Hold
1,158
– – 0.02% 122
2021
Q4 		$53K Buy
+1,158
New +$73.4K 0.03% 123

Other funds holding HELP

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.73B AUM 24.11% 1-Year Est. Return

Powell Investment Advisors's HELP Position: Q3 2024 in Review

Powell Investment Advisors sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2024, closing a stake of 1,579 shares — an estimated $16.3K sold.

Powell Investment Advisors first reported a position in HELP in Q4 2021 and held it in 11 quarters. The position peaked at $53K in Q4 2021. 46 funds tracked by Wall St. Rank hold HELP as of Q3 2024.

  • Powell Investment Advisors reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Powell Investment Advisors sold 1,579 Helus Pharma Inc. Common Stock shares in Q3 2024, an estimated $16.3K.
  • Powell Investment Advisors first reported a position in Helus Pharma Inc. Common Stock in Q4 2021 and held it in 11 quarters.
  • Powell Investment Advisors's Helus Pharma Inc. Common Stock position peaked at $53K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2024.

Based on Powell Investment Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.